Material
Early immune response to the largely used Mycobacterium bovis bacillus Calmette-Guérin (BCG) intradermal vaccine remains ill defined. Three days after BCG inoculation into the mouse ear, in addition to neutrophils infiltrating skin, we observed CD11b P romptly after pathogen entry or danger signal encounter, early tissue inflammatory infiltrate includes neutrophils, the master cell type involved in controlling invaders, and monocytes (MOs), which mature in dendritic cells (DCs) or tissue macrophages. MOs circulating in the blood are heterogeneous in phenotype and function (1) . In the mouse, the different levels of CX3CR1 expression, the fractalkine receptor, and Ly-6C, a glycosylphosphatidylinositol-anchored protein, at the cell surface define two different subsets (2): CX3CR1 lo Ly-6C hi MOs migrate to inflamed tissues upon CCR2 activation of the host response against infection (3) , and CX3CR1
hi Ly-6C lo CCR2 2 MOs replenish the resident tissue macrophage pool under steady-state conditions (2) . Blood MOs with intermediate levels of Ly-6C may represent different differentiation phases of a continuum (4) (5) (6) or bona fide MO subsets (7) . Bone marrow-derived precursors for neutrophils and MOs (8) , sometimes referred to as band-cells or ring-shaped nucleus cells, also circulate under steady-state conditions (9) . Inflammation, intertwined with the innate immune response, becomes involved in adaptive immunity when DCs prime T cells for control of primary infection or for protection against a second pathogen encounter. In response to moderate inflammatory signals, CX3CR1
lo Ly-6C hi MOs migrate to the draining lymph node, where they differentiate in DCs and prime the T cell response (10) . Upon vaccination, the consequences of these early immune events on protective immunity remain ill defined. Notably, understanding inflammatory/innate response to the tuberculosis vaccine Mycobacterium bovis bacillus Calmette-Guérin (BCG) might give some clues as to why BCG does not consistently protect adults against pulmonary disease (11) . We showed that during BCG vaccination in mouse models, neutrophils shuttle BCG from the skin to the draining lymph node (12) and establish cross-talk with DCs to facilitate the presentation of Ag to T cells (13) .
Inflammation is a double-edged sword that must be tightly controlled. The first checkpoint occurs during acute inflammation and entails the active coordination of suppression of neutrophil influx and local release of molecular host response machinery. The second checkpoint involves backup processes that dampen the inflammatory T cell responses to avoid chronic inflammation and tissue injury. These include the production of anti-inflammatory cytokines by innate cells and generation of regulatory T cells. Myeloid-derived suppressor cells (MDSCs) suppress T cells in pathological situations such as cancer (14) or sepsis (15) . MDSCs constitute a heterogeneous population of CD11b + Gr1 (Ly-6C/Ly-6G) + cells, comprising MOs, granulocytes, and DCs at different stages of differentiation (16) . In tumor-bearing mice, MDSCs expand in the blood, spleen, and tumors, where they contribute to tumor-associated Ag-specific T cell suppression and tolerance via NO production (17, 18) .
We characterized innate/inflammatory cells infiltrating the skin early after BCG injection and their effects on T cell priming in the draining lymph node in a mouse model of intradermal BCG vaccination. During the first 3 d, after BCG injection, we observed the recruitment of a subset of CD11b + myeloid-derived cells in addition to neutrophils in the skin. These CD11b + cells produced inducible NO synthase (iNOS) but were unable to kill mycobacteria. However, they blocked T cell proliferation and dampened Ag-specific priming in the draining lymph node through NO production in vivo. Our findings thus showed that BCG vaccination recruits innate MDSCs, similar to those infiltrating tumors in mice, that impair the in vivo T cell response.
Materials and Methods
Injection into ear skin in mice and mycobacterial strains , and OT-II mice were housed in our animal care facility under specific pathogen-free conditions. After anesthesia with 5 ml xylamine 2% (v/v) and 1 mg ketamine, each mouse received 10 ml culture containing 10 6 CFUs of mycobacteria per ear dorsum. Strains used were BCG Pasteur 1173P2, wild-type or recombinant producing the enhanced GFP (EGFP) (strain Myc409) (12) 
Neutrophil depletion
Cells were depleted in vivo by one 200-mg i.p. NIMP-R14 (Rat IgG2b) (20) or 1A8 (21) mAb injection 15 h before BCG injection in skin and two 145-mg i.p. injections 24 and 48 h after the first mAb injection. NIMP-R14 and 1A8 gave similar results (Supplemental Fig. 1 ), therefore we used NIMP-R14 throughout the study. The rat IgG2b isotype mAb HB152 (kindly provided by Genviève Milon) was used in control mice. Neutrophils were depleted in vitro from skin explant (SkEx) cells after anti-Ly-6G labeling and using negative magnetic bead selection according to the manufacturer's instructions (Miltenyi Biotec, Bergisch Gladbach, Germany).
SkEx, blood, and bone marrow cell preparation Dorsal and ventral halves of ears from five mice were split and layered on complete RPMI 1640 medium for 24 h at 37˚C to recover SkEx cells as described (12) . Blood cells from the retro-orbital sinus were collected in PBS containing 10 U/ml heparin (Sanofi Aventis, Bridgewater, NJ). Blood (3 ml) was mixed with 17-18 ml Dextran 500 (Fluka, Sigma-Aldrich) 1.25% (w/v) in PBS. Erythrocytes were isolated by sedimentation for 20 min at 20˚C. Leukocyte-rich suspension was collected and centrifuged for 5 min at 1300 rpm, and the remaining erythrocytes were lysed using 1 ml RBC lysing buffer (Sigma-Aldrich) before staining for flow cytometry. Bone marrow was flushed from the femurs and tibias of C57BL/6 mice. Total cells were plated in DMEM (Life Technologies, Rockville, MD) medium, containing 10% FCS and 10% L929 supernatant for macrophages, or IMDM medium (Cambrex, East Rutherford, NJ) containing 10% FCS and 1% J558 cell supernatant for DCs, as previously described (22) . DCs were 95% CD11c + , CD11b 
T cell assays
OT-II mice were injected in ear skin with 10 6 BCG CFUs with or without 50 mg OVA (Sigma-Aldrich). Total lymph node cells were prepared from three individual mice, and 2 3 10 5 cells were cultured in 200 ml HL-1 medium (Cambrex) with 10 U/ml penicillin and streptomycin and 1 mM glutamine. OVA protein (5 mg/ml; Sigma-Aldrich) was added to stimulated cells For intracellular staining, cells were permeabilized with Cytofix-Cytoperm kit (554714, BD Pharmingen) and incubated with rabbit polyclonal anti-NO synthase 2 (NOS2) (SA-200, Biomol International, Plymouth Meeting, PA) followed with Alexa Fluor 594-conjugated goat anti-rabbit IgG (Molecular Probes) or with anti-TNF (BD Bioscience). Data were analyzed using FACSCalibur; 3 3 10 4 events were collected and analyzed with FlowJo software (BD Bioscience).
Immunohistochemistry
In situ expression of Ly-6C + was assessed in ear skin snap-frozen and embedded in 1.5 ml optimum cutting temperature compound (Tissue Tek, Sakura, Torrance, CA). Cryostat sections (5-8 mm) were fixed in cold 80% (v/v) acetone and 20% (v/v) ethanol, air dried, and blocked for 30 min in BSA containing medium (Vector Laboratories, Burlingame, CA). Sections were incubated with anti-Ly-6C and Alexa Fluor 633-or 594-conjugated goat anti-rat IgG (Molecular Probes). Rabbit polyclonal anti-NOS2 and Alexa Fluor 594-or 488-conjugated goat anti-rabbit IgG were used for NOS2 detection.
Microscope and image acquisition
For immunohistochemistry on tissues, images were acquired on microscope (Axioskop, Zeiss, Oberkochen, Germany) with objective (Achroplan 203/ 0.45, Zeiss) using a camera (Leica Camera AG, Solms, Germany) and Leica Qwin software (Leica) or on a confocal microscope equipped with a blue laser diode (405 nm), an Argon laser (488 nm), helium-neon laser (543 nm) and objective (Plan Apochromat 633/1.4 NA, Zeiss) with LSM 510 V3.2 software (Zeiss). For cytocentrifuged cells, images were acquired on a light microscope (Axioskop, Zeiss) equipped with an oil iris objective (Achroplan 1003/1.25 NA, Zeiss), with a camera (Leica 300F) and Qwin software (Leica). For fluorescence microscopy on SkEx cells, images were acquired on a microscope (eclipse E600; Nikon, Melville, NY) equipped with an objective (Plan Apochromat 603/1.40, Nikon) with camera (DXM 1200F, Nikon) using imaging software (Nikon, NIS document BR). All images were transferred to Adobe Photoshop (Adobe Systems, San Jose, CA) for editing figures.
Statistical analysis
Values are expressed as mean 6 SD unless otherwise indicated. The Kruskal-Wallis test was used first to ascertain that significant variance existed among the groups studied. The Mann-Whitney U test was then used to test statistical significance of the differences between two groups, and p values (indicated on each figure) of less than 0.05 were considered significant. All calculations were made using Prism 5.0 software (GraphPad, San Diego, CA). 2 gated cells. The Ly-6C int population that increased in number upon BCG injection did not express CX3CR1. Cytocentrifuged cells were observed under a light microscope harbored ring-shaped nuclei (R1, May-Grunwald-Giemsa stain). Bar, 10 mM; original magnification 3100. levels. They displayed ring-shaped nuclei, as previously described for immature myeloid cells (9) (Fig. 1F) Upon acute inflammation, an initial massive influx of neutrophils is followed by the recruitment of MOs, which help to resolve inflammation. The nature of extravasation kinetics (25) and interplay between the different subsets remains unclear (26, 27 
Results
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2 cells 24 and 72 h after BCG injection ( Fig. 2A) . Their numbers were 2.1 times and 2.9 times higher at 24 and 72 h after neutrophil depletion than in isotype-injected control mice (Fig. 2B) . We did not detect CX3CR1
) SkEx cells at these early time points (data not shown), although we observed CX3CR1 + SkEx cells by day 25 following BCG injection in the ear (Supplemental Fig. 2 ). Neutrophil-depleted C57/BL6 mice were injected with the BCG strain Myc409 producing EGFP (12). We did not detect Ly-6C + cells in ear cryosections 4 h after BCG injection in these mice. By contrast, large numbers of Ly-6C + cells infiltrated the dermis between 24 and 72 h (Fig. 2C) , indicating that these cells were recruited from the periphery. These cells mostly colocalized with BCG ( Fig. 2C) showed similar levels for EGFP staining, suggesting that they have similar capacities to phagocytose BCG (Fig. 3A) . Mouse neutrophils produce TNF in response to BCG infection (13) . Similar levels of intracellular TNF staining were observed for neutrophils and CD11b + Ly-6C int Ly-6G 2 cells after BCG infection (Fig. 3A) .
Only CD11b + Ly-6C int Ly-6G 2 cells showed intense staining for iNOS (Fig. 3B, in red) , an enzyme playing a major role in mycobacterial control. Whereas few iNOS + cells were detected in nondepleted mice, almost all SkEx cells displayed high iNOS staining in neutrophil-depleted mice. Accordingly, NO production by SkEx cells was eight times higher in neutrophil-depleted than in control mice (Fig. 3C) . In situ analysis revealed colocalization of Ly-6C + cells (blue) with iNOS (red) and BCG (Myc409, green) (Fig. 3D) and absence (NIMP-R14 injection) of neutrophils, although a higher number of these cells were found in the neutrophil-depleted mice.
neutrophils (Fig. 3E ) upon BCG injection, illustrating the specificity of these myeloid cells to produce iNOS both in blood and tissues. Despite their high numbers in skin from neutrophil-depleted animals, the BCG load 4 h after injection did not decrease for the next 3 (Fig. 4A) (Fig. 4B) . Therefore, despite high levels of NO production, CD11b + Ly-6C int Ly-6G 2 cells did not kill pathogenic or nonpathogenic mycobacteria, whereas classically activated macrophages did (Supplemental Fig. 3 ). 
CD11b
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2 SkEx cells were observed in CX3CR1 +/GFP mice injected with M. smegmatis or BCG (data not shown). However, intracellular iNOS was barely detected in SkEx cells from M. smegmatis-injected ears (Fig. 5E) . Hence, MyD88-mediated signaling appeared to be necessary for CD11b (Fig. 6A ). SkEx cells from control mice, including neutrophils, and possibly some professional APCs such as DCs, were able to stimulate allogenic T cells. However, in vitro neutrophil depletion abolished SkEx cell stimulatory activity. Similarly, iNOS-rich SkEx cells from in vivo neutrophil-depleted animals were unable to stimulate T cells. The iNOS inhibitor L-NMMAwas added to cell cultures and inhibited SkEx cell-mediated T cell suppression. Fixed numbers of C57BL/6 SkEx cells from BCG-vaccinated mice were then mixed with increasing numbers of bone marrow-derived BCG-activated C57BL/6 DCs to improve stimulatory capacity of BALB/c allogenic CD3 T cells (Fig. 6B) . SkEx cells were either obtained in vivo from neutrophil-depleted mice or in vitro from neutrophil-depleted cells. In both cases, SkEx cells completely suppressed allogenic T cell proliferation (Fig. 6B ) and IFN-g secretion (Supplemental Fig. 4 ) despite the presence of strongly stimulating BCG-activated DCs. This effect was observed even at the highest DC/T cell ratio and was reversed by L-NMMA addition. iNOS + cells from isotype-treated mice suppressed T cell proliferation to a lesser extent than iNOS + cells from neutrophil-depleted animals but still prevented IFN-g secretion (Supplemental Fig. 4) . Hence, BCG vaccination in skin recruited 
2 cells were reminiscent of MDSCs previously described under pathological conditions such as in sepsis and cancer (14) . We therefore called these cells innate MDSCs (inMDSCs). We also found that jointly recruited neutrophils counterbalanced inMDSC-mediated T cell suppression in vitro. We then investigated a potential effect of inMDSCs on T cell priming in the draining lymph node. iNOS-producing CD11c 2 cells were detected in the auricular lymph node by immunohistochemistry 4 and 72 h after BCG injection in the ear skin. iNOS staining under the lymph node capsule was stronger in neutrophil-depleted than in isotype-treated mice (Fig. 6C) . This suggested that, as previously shown for neutrophils (12) , inMDSCs were able to reach the lymph node. No iNOS + cells were detected in mock-injected mice. Increased recruitment of iNOS + cells in the draining lymph node by neutrophil depletion had no impact on BCG transport from the skin (Fig. 6D) , suggesting that similar amounts of BCG-derived Ags were available for early T cell priming in both neutrophil-proficient and neutrophil-depleted mice.
Neutrophil-depleted or isotype-treated TCR-Ova-specific OT-II mice (32) were coinjected with BCG and Ova in the ear skin. Draining lymph node cells were harvested after 72 h, and IFN-g SFCs were counted after in vitro restimulation with Ova protein.
In correlation with increased iNOS + cells in draining lymph node, the number of IFN-g SFCs in neutrophil-depleted treated mice was three times lower than in controls (Fig. 6E) . Recent studies showed that ATRA injection depletes MDSCs in mice tumors (33) . We observed that Ova-specific IFN-g SFC levels following ATRA treatment in OT-II mice injected with BCG and Ova in ear skin were five times higher than those in vehicle-treated mice, suggesting that inMDSC elimination in vivo strongly increased T cell priming following BCG vaccination (Fig. 6F) . These data show that the coordinated early recruitment of neutrophils and inMDSCs regulated early T cell priming in response to BCGderived Ags after vaccination in skin.
Discussion
Innate MDSCs, phenotypically characterized by Ly-6C, CD11b, and CD31 cell-surface expression and functionally defined by strong NOmediated in vitro T cell suppression, were recruited to the dermis during the very early stages following BCG vaccination. These cells didnot expressCD115or Ly-6G atthecellsurface,suggesting thatthey were not MOs or neutrophils. MDSCs were recently defined in disease states including overwhelming infection or cancer (14) . MDSCs originate in the bone marrow, circulate in the blood, and accumulate in lymphoid tissue after the onset of inflammation. They act as a regulatory feedback mechanism to suppress T cells (16) . Mouse MDSCs are phenotypically characterized by a combination of markers, including CD11b and Gr1 (Ly6-C/G), and are functionally defined by their potent NO-mediated suppression of T cells (16) . Recently, two subsets have been described in mouse tumors: granulocytic MDSCs that express both Ly-6C and Ly-6G and monocytic MDSCs that only express Ly-6C (34, 35) . Both subsets are able to block T cell proliferation by different mechanisms associated with the metabolism of L-arginine (14) . iNOS is the main effector for T cell suppression by monocytic MDSCs (34) . Whereas MDSCs accumulate in lymphoid tissues, inMDSCs appeared early after BCG injection, first in the blood and skin, where they peaked by day 3. In mice, iNOS and NO production induced by classically activated macrophages is essential for the destruction of mycobacteria (36) . However, pathogenic mycobacteria escape this harsh environment by adapting their genetic program for protection against NO (37), iNOS exclusion from the phagosome (38) , and macrophage arginase 1 induction (39) . Despite phagocytosis and high iNOS levels, skin inMDSCs were unable to kill BCG or the fast-growing M. smegmatis, showing that mycobacteria were also able to escape the hostile NO environment in inMDSCs.
We found that skin CD11b + Gr1 + cells, constituting the early BCG-induced inflammatory infiltrate, were composed of Ly-6C int Ly-6G
2 cells and Ly-6C + Ly-6G + neutrophils. Despite expressing iNOS and TNF, these cells differed from recently characterized TNF and iNOS-producing DCs (3) by a number of aspects: they did not express CD115 or CD11c, their migration from blood to skin was CCR2 independent, and they exerted suppression instead of activation on T cells. However, in respect to their immature phenotype, we do not exclude that inMDSCs might convert to TNF and iNOS-producing DCs under some circumstances. Unexpectedly, we did not detect the recently described inflammatory CX3CR1 lo MO population between 2 (data not shown) and 72 h http://jimmunol.org/ after BCG inoculation in the skin. However, migrating CX3CR1 + SkEx cells were observed by day 25 after BCG inoculation (Supplemental Fig. 2 ), demonstrating that these cells were recruited to skin at later time points. Although we cannot exclude that minute amounts of CX3CR1 + Ly-6C + MOs were present during the early stages of infection in skin, the BCG-induced environment may delay the recruitment of inflammatory MOs. Consistent with this, Rotta et al. (40) described that strong inflammatory signals, delivered through TLR4 from endotoxin or Salmonella typhimurium injection in skin, blocked the migration of inflammatory MOs migration and differentiation of DCs in the draining lymph node, occurring under mild inflammatory conditions (10) . Upon disruption of homeostasis, the content of the inflammatory cell infiltrate must be tightly regulated. It is widely accepted that neutrophils infiltrate the lesion first and are swiftly followed by MOs, although the role played by neutrophils in the control of MO recruitment is unclear (26, 27, 41) . The poor specificity of anti-Gr1 (Ly-6C/Ly-6G) Ab has contributed to confusion in the field. Upon BCG injection, we observed coordinated fluctuations in neutrophil and inMDSC levels in skin infiltrates over time; although neutrophils remained the predominant cell type, inMDSCs numbers increased at later time points. Moreover, the specific depletion of neutrophils markedly increased the recruitment of inMDSCs. These data suggested that the recruitment of inMDSCs was suppressed by neutrophils.
The recruitment of neutrophils and inMDSCs to skin was regulated by different signaling pathways. Whereas neutrophils did not need MyD88 to reach the skin, inMDSCs were strictly dependent on MyD88 signaling, highlighting differences between the host mechanisms controlling these two cell populations. MyD88-deficient mice cannot suppress lung Mycobacterium tuberculosis (28, 29) or BCG (42) multiplication. Tissue infiltrates in these mice also display higher levels of Ly-6G + granulocytic cells than those in MyD88 +/+ mice (28), consistent with the MyD88-independent recruitment of neutrophils in response to mycobacteria. Given the suppressive function of inMDSCs, the extensive lung inflammation observed in mycobacteriainfected MyD88 2/2 mice (28, 42) could be partly due to unrestricted neutrophils influx and/or the loss of inMDSCs. MyD88 signaling is at the crossroads of TLR-, IL-1R-, and IL-18R-dependent pathways. We did not observe the impaired influx of inMDSCs in skin in TLR 2 3 4 2/2 , TLR 9
2/2
, or IL-1R 2/2 mice. The receptor upstream from MyD88 involved in the recruitment of these cells remains unknown. However, levels of inMDSC-induced iNOS and NO production in IL-1R 2/2 mice, which, similarly to MyD88 2/2 mice (31), are susceptible to tuberculosis infection, were greatly reduced. The b form of pro-IL-1-induced gastric inflammation and cancer have recently been linked to the recruitment of mouse MDSCs (43) . Hence, the b form of pro-IL-1 and IL-1R appear to be master regulators of inMDSC activation. NO produced by inMDSCs was unable to inhibit mycobacterial growth, but completely suppressed T cell proliferation in vitro and curtailed T cell priming in vivo. In BCG-injected mice, increased recruitment of iNOS + cells to the lymph node after neutrophil depletion correlated with decreased T cell priming. Conversely, in vivo treatment with ATRA, which eliminates MDSCs, increased T cell priming (33) . In mice, treatment with ATRA significantly enhanced cancer vaccine efficacy (44) . In mycobacteria-induced experimental autoimmune encephalomyelitis models, CD11b produced by neutrophils (45) . These feedback mechanisms have major effects on experimental autoimmune encephalomyelitis pathogenesis. Our data are consistent with the hypothesis that the coordinated innate influx of neutrophils and inMDSCs, and the associated NO/O 2 2 balance, regulates BCG Ag-specific T cell priming during vaccination. This mechanism may control the BCG-induced T cell response level and avoid excessive tissue inflammation. Alternatively, the recruitment of propathogenic cells, such as inMDSCs, which are unable to kill BCG and delay T cell priming, could be an additional mechanism employed by slow-growing mycobacteria to parasitize their host.
